Intravenous DMSO for Parkinson’s and ALS: Peaks, Sterility, and Hemolysis
This is an original summary of publicly available health commentary and cited research. It is health news and commentary for SupportFreedom readers—not medical advice, a diagnosis, or a treatment plan. Category framing: Health → DMSO. Consult a licensed clinician before changing care.
Why IV
Animal neuroprotection and infusion anecdotes motivate careful IV study versus oral steady levels.
Human footholds
Hoang DMSO–bicarbonate pain infusions; outpatient drips ~3–10%; ICU trauma doses are different.
Hard constraints
Hemolysis near ~30%; pyrogen-free filtration; PTFE membranes; DEHP tubing concerns.
Conservative sketch
~3–4% weekly concepts under clinical supervision—not DIY.
Framing
Paid personal research essay; keep neurology standards primary.
For SupportFreedom readers, separate three layers carefully: (1) laboratory and historical clinical literature, (2) curated patient testimonials, and (3) regulatory or commercial incentives that shape guidelines. DMSO coverage often mixes all three—newsworthy, and why cautious language matters.
Practical hygiene themes recur across careful DMSO writing: pharmaceutical-grade purity claims, clean skin before topical use, awareness that the solvent can carry other chemicals inward, and respect for drug-interaction potential. Those points remain relevant whether a source is enthusiastic or skeptical.
Nothing in this paraphrase replaces emergency care for stroke, spinal injury, acute vision loss, severe infection, or suspected cancer. Established clinicians, imaging when indicated, and open discussion of evidence quality still come first. Health → DMSO posts inform civic and personal curiosity about neglected therapies without turning commentary into a protocol.
Editors should note publication date, paywall status, and whether claims cite primary papers versus secondary Substack synthesis. This draft is tuned for WordPress readability while remaining an original paraphrase for SupportFreedom.
For SupportFreedom readers, separate three layers carefully: (1) laboratory and historical clinical literature, (2) curated patient testimonials, and (3) regulatory or commercial incentives that shape guidelines. DMSO coverage often mixes all three—newsworthy, and why cautious language matters.
Practical hygiene themes recur across careful DMSO writing: pharmaceutical-grade purity claims, clean skin before topical use, awareness that the solvent can carry other chemicals inward, and respect for drug-interaction potential. Those points remain relevant whether a source is enthusiastic or skeptical.
Source
Original article: 472. Intravenous DMSO for Parkinson’s, ALS, and more — Robert Yoho, MD.
editor's pick
news via inbox
Nulla turp dis cursus. Integer liberos euismod pretium faucibua

